Related Experiment Video
Updated: Mar 17, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Clinical commissioning of a novel compact multi-room pencil beam scanning proton therapy system
Eunsin Lee1, Austin M Faught1, Hyeri A Lee1
1Department of Radiation Oncology, The Ohio State University, Columbus, Ohio, USA.
Purpose:
To present the clinical commissioning of the world's first multi-room Varian ProBeam 360° proton pencil beam scanning system.
Methods:
The state-of-the-art system includes two clinical treatment rooms with 360° rotating gantries, a superconducting cyclotron, an energy selection system, a beam transport system and scanning nozzles. These components deliver proton spots ranging from 3.97 to 30.03 g/cm2 to arbitrarily shaped target volumes over a scanning area of 25 cm × 25 cm at isocenter. Proton beam ranges (R80) were measured and verified independently in both gantry rooms to ensure agreement with beam specifications. Dosimetric parameters, including depth dose curves, in-air spot profiles and dose per monitor unit (MU) as a function of energy, were measured and used to create a dose calculation model in the RayStation treatment planning system (TPS). Treatment plans with various sizes of spread-out Bragg peaks (SOBPs) and simulated patient plans for a range of clinical sites were created and measured at various depths to validate the TPS's beam model accuracy. Additionally, beam matching between the two rooms was performed and validated.
Results:
Across the full energy range of 69-218 MeV, the measured R80 in both rooms were identical within 0.4 ± 0.2 mm deviation from the expected nominal range. In-air spot sizes agreed within 5.7 ± 1.8% while outputs matched within 1.0 ± 0.5%. The average point dose difference was 0.2 ± 0.7% for over 80 measurements of SOBP validation plans from the TPS calculations and all planar dose measurements matched TPS calculations with over 90% of data passing a 2mm/2% gamma criterion. All patient plans were validated at a 3mm/3% criterion and demonstrated over 90% of data passing.
Conclusion:
Both gantry systems were successfully commissioned for clinical use. Accurate measurements with robust validation ensured essential parameters for beam delivery and dosimetry were characterized for safe patient treatments.

